[ET Net News Agency, 8 April 2024] HIGHTIDE-B (02511) remained unchanged at HK$5.4.
It hits an intra-day high of HK$5.57, and an intra-day low of HK$5.35, hitting a
historical low. The total shares traded was 34,500, with a value of HK$188,750. The active
buy/sell ratio is 57:43, with net buying turnover of HK$24,515. BARCLAYS CAPITAL ASIA
accounts for greatest net responsive buying turnover of HK$6,242, with volume weighted
average price of HK$5.35. FUTU SEC INT'L accounts for greatest net responsive selling
turnover of HK$14,125, with volume weighted average price of HK$5.524.
Basic Information
=================
----------------------------------
Nominal 5.400 % Chg +0.00%
High 5.570 Low 5.350
Shares Tr 34,500 Turnover 188,750
10-D SMA 5.794 %H.V 105.049
20-D SMA 6.744 VWAP 5.471
50-D SMA 9.527 RSI14 24.368
----------------------------------
Status: Hitting a historical low, active buy/sell ratio is 57:43, with net buying turnover
of HK$24,515
Performance of stocks in the same sector or of relevance
========================================================
Stock (Code) Price (HK$) Change (%)
-----------------------------------------------
HIGHTIDE-B (02511) 5.40 Unchanged
GENSCRIPT BIO (01548) 12.82 -5.32
INNOVENT BIO (01801) 36.45 +1.96
EVEREST MED-B (01952) 22.95 +5.03
WUXI BIO (02269) 13.94 +4.34
TIGERMED (03347) 30.15 +8.26
BEIGENE (06160) 90.95 +0.28
SCICLONE PHARMA (06600) 17.86 -0.56
SKB BIO-B (06990) 145.00 +4.84
AKESO (09926) 46.25 +2.55
-----------------------------------------------
(ed)